Insider · CIK 0001196573
Christopher U Missling
Files at AVXL (ANAVEX LIFE SCIENCES CORP.). First filing -, latest -.
In brief
Christopher U Missling files SEC Form 4 as CEO, president and director at AVXL (ANAVEX LIFE SCIENCES CORP.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Christopher U Missling has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 14 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jan 6, 2026 | AVXL ANAVEX LIFE SCIENCES CORP. | AGrant or award Stock Option (Right to Buy)derivative | +125,000 | $0.00 | $0 | 125,000 | Jan 9, 2026 |
| Oct 2, 2025 | AVXL ANAVEX LIFE SCIENCES CORP. | AGrant or award Stock Option (Right to Buy)derivative | +125,000 | $0.00 | $0 | 250,000 | Oct 3, 2025 |
| Sep 11, 2025 | AVXL ANAVEX LIFE SCIENCES CORP. | MOption exercise Common Stock | +187,500 | $5.04 | $945k | 1,655,213 | Sep 12, 2025 |
| Sep 11, 2025 | AVXL ANAVEX LIFE SCIENCES CORP. | FTax withholding Common Stock | -145,048 | $9.58 | $1.4M | 1,510,165 | Sep 12, 2025 |
| Sep 11, 2025 | AVXL ANAVEX LIFE SCIENCES CORP. | MOption exercise Stock Option (Right to Buy)derivative | -187,500 | $0.00 | $0 | 0 | Sep 12, 2025 |
| Aug 20, 2025 | AVXL ANAVEX LIFE SCIENCES CORP. | AGrant or award Stock Option (Right to Buy)derivative | +125,000 | $0.00 | $0 | 125,000 | Aug 22, 2025 |
| Apr 28, 2025 | AVXL ANAVEX LIFE SCIENCES CORP. | AGrant or award Stock Option (Right to Buy)derivative | +125,000 | $0.00 | $0 | 125,000 | Apr 30, 2025 |
| Mar 24, 2025 | AVXL ANAVEX LIFE SCIENCES CORP. | MOption exercise Common Stock | +500,000 | $0.92 | $460k | 1,750,210 | Mar 26, 2025 |
| Mar 24, 2025 | AVXL ANAVEX LIFE SCIENCES CORP. | FTax withholding Common Stock | -282,497 | $9.63 | $2.7M | 1,467,713 | Mar 26, 2025 |
| Mar 24, 2025 | AVXL ANAVEX LIFE SCIENCES CORP. | MOption exercise Stock Option (Right to Buy)derivative | -500,000 | $0.00 | $0 | 0 | Mar 26, 2025 |
| Jan 15, 2025 | AVXL ANAVEX LIFE SCIENCES CORP. | AGrant or award Stock Option (Right to Buy)derivative | +166,666 | $0.00 | $0 | 166,000 | Jan 17, 2025 |
| Jan 15, 2025 | AVXL ANAVEX LIFE SCIENCES CORP. | AGrant or award Stock Option (Right to Buy)derivative | +125,000 | $0.00 | $0 | 125,000 | Jan 17, 2025 |
| Dec 19, 2024 | AVXL ANAVEX LIFE SCIENCES CORP. | AGrant or award Stock Option (Right to Buy)derivative | +125,000 | $0.00 | $0 | 125,000 | Dec 23, 2024 |
| Nov 19, 2024 | AVXL ANAVEX LIFE SCIENCES CORP. | AGrant or award Stock Option (Right to Buy)derivative | +125,000 | $0.00 | $0 | 250,000 | Dec 6, 2024 |
Questions about Christopher U Missling
Answered from the filings on this page, as of the latest one.
Is Christopher U Missling buying or selling?
Christopher U Missling has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Christopher U Missling's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Christopher U Missling has 0.
Where does Christopher U Missling file Form 4?
Christopher U Missling has filed Form 4 at AVXL (ANAVEX LIFE SCIENCES CORP.) as President and CEO. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.